Atlas Trials

Study of BBP-418 in Patients With LGMD2I

Clinical trial NCT04800874 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04800874
Sponsor
ML Bio Solutions, Inc.
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
LGMD2I
Start date
2021-02-18
Primary completion
2026-11-01
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.